Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1746]

Treatment updates in Merkel cell carcinoma

Dr Paul Nghiem - University of Washington, Seattle, USA

Treatment updates in Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )

ASCO 2018: Latest in bladder cancer treatments

Prof Thomas Powles & Prof Shahrokh Shariat

ASCO 2018: Latest in bladder cancer treatments ( Prof Thomas Powles & Prof Shahrokh Shariat )

ASCO 2018: Integrating genomic data throughout treatment for prostate cancer

Prof Kurt Miller and Prof Bertrand Tombal

ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )

Zoptarelin no better than doxarubicin for second-line advanced endometrial...

Dr David Miller - The University of Texas Southwestern Medical Center

Zoptarelin no better than doxarubicin for second-line advanced endometrial cancer ( Dr David Miller - The University of Texas Southwestern Medical Center )

Immunotherapy trials and hyperprogressive disease

Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

Immunotherapy trials and hyperprogressive disease ( Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )

First-in-human phase 1 study of TAK-931 for solid tumours

Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan

First-in-human phase 1 study of TAK-931 for solid tumours ( Dr Toshio Shimizu - National Cancer Center Hospital (NCCH), Tokyo, Japan )

Web-mediated follow-up via patient-reported outcomes vs. routine surveillance...

Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France

Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in lung cancer patients ( Dr Fabrice Denis - Jean Bernard Centre, Le Mans, France )

The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for...

Prof William Wierda - MD Anderson Cancer Center, Houston, USA

The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients ( Prof William Wierda - MD Anderson Cancer Center, Houston, USA )

Linking Lynch Syndrome and microsatellite instability in tumours

Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA

Linking Lynch Syndrome and microsatellite instability in tumours ( Dr Zsofia Kinga Stadler - Memorial Sloan Kettering Cancer Center, New York, USA )

Editor’s Choice for May 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor’s Choice for May 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

Movement and growth of cells throughout the leptomeningeal space

Dr Adrienne Boire - Memorial Sloan Kettering Cancer Centre , New York, USA

Movement and growth of cells throughout the leptomeningeal space ( Dr Adrienne Boire - Memorial Sloan Kettering Cancer Centre , New York, USA )

Diagnostics and classification of brain tumours

Dr David Louis - Massachusetts General Hospital, Boston, USA

Diagnostics and classification of brain tumours ( Dr David Louis - Massachusetts General Hospital, Boston, USA )

More from ecancer